Obesity Clinical Trial
— SukalmenaOfficial title:
Feasibility Study for the Development of a Nutritional-culinary Programme to Tackle Overweight or Obesity as a Strategy to Promote Adherence to a Healthy Dietary Pattern.
NCT number | NCT04908163 |
Other study ID # | PI2021067 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 26, 2021 |
Est. completion date | July 31, 2022 |
Verified date | October 2023 |
Source | Basque Culinary Center Fundazioa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Currently, one of the main health challenges of public health is to improve the quality of life of people with chronic non-communicable diseases, through new strategies that promote healthy eating habits and lifestyles. Within the new strategies that aim to promote and improve the eating habits of the population, "Sukalmena-InAge" is proposed as a tool for transforming health, where culinary skills and nutritional knowledge converge as a new paradigm to promote health. The merging of culinary knowledge and nutritional education has been coined under the term Culinary Medicine. The present project is presented as an innovative strategy to improve dietary habits of overweight/obese people. To this end, volunteers will participate in an intervention that will be based on cooking workshops and nutritional education. In this sense, participants will receive different cooking and nutritional education sessions in order to be able to give them resources to cook in an easy, enjoyable and healthy way. The study will evaluate the effect that this nutritional-culinary intervention programme might exert on health and will compare these results with the effects obtained providing a more traditional nutritional education. The potential effects will be evaluated through the measurement of specific biochemical parameters related to the most prevalent chronic diseases ( insulin, glucose, total cholesterol, triglycerides, among others). In addition, the measurement of advanced glycation end products (AGEs) in tissue will be carried out. High consumption of AGEs, could induce negative effects on health and has been correlated with the type of food consumed, but also with the culinary techniques used for their preparation.
Status | Completed |
Enrollment | 56 |
Est. completion date | July 31, 2022 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 70 Years |
Eligibility | Inclusion Criteria: - Overweight or obesity (BMI between 25 and 35 kg/m2) - Low score in the screening questionaire "Homecooking Quality Index" (HQI) Exclusion Criteria: - Pregnant or lactating women. - Serious medical condition precluding dietary intervention or limiting survival to less than one year. - Illicit drug use, chronic alcoholism. - Participation in any clinical trial with drugs or dietary intervention during the year prior to inclusion. - Weight loss intervention (surgical treatment, dietary or pharmacological treatment) during the last year - Difficulty or major drawbacks to change dietary habits and follow Mediterranean diet (allergies, intolerances). |
Country | Name | City | State |
---|---|---|---|
Spain | Basque Culinary Center Fundazioa | Donostia-San Sebastián | Gipuzkoa |
Lead Sponsor | Collaborator |
---|---|
Basque Culinary Center Fundazioa | University of Navarra |
Spain,
Abate G, Marziano M, Rungratanawanich W, Memo M, Uberti D. Nutrition and AGE-ing: Focusing on Alzheimer's Disease. Oxid Med Cell Longev. 2017;2017:7039816. doi: 10.1155/2017/7039816. Epub 2017 Jan 12. — View Citation
Chou PS, Wu MN, Yang CC, Shen CT, Yang YH. Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease. J Alzheimers Dis. 2019;72(1):191-197. doi: 10.3233/JAD-190639. — View Citation
Irl B H, Evert A, Fleming A, Gaudiani LM, Guggenmos KJ, Kaufer DI, McGill JB, Verderese CA, Martinez J. Culinary Medicine: Advancing a Framework for Healthier Eating to Improve Chronic Disease Management and Prevention. Clin Ther. 2019 Oct;41(10):2184-2198. doi: 10.1016/j.clinthera.2019.08.009. Epub 2019 Sep 20. — View Citation
Mills S, White M, Brown H, Wrieden W, Kwasnicka D, Halligan J, Robalino S, Adams J. Health and social determinants and outcomes of home cooking: A systematic review of observational studies. Appetite. 2017 Apr 1;111:116-134. doi: 10.1016/j.appet.2016.12.022. Epub 2016 Dec 23. — View Citation
Zaharia OP, Kupriyanova Y, Karusheva Y, Markgraf DF, Kantartzis K, Birkenfeld AL, Trenell M, Sahasranaman A, Cheyette C, Kossler T, Bodis K, Burkart V, Hwang JH, Roden M, Szendroedi J, Pesta DH. Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. Eur J Nutr. 2021 Oct;60(7):3811-3818. doi: 10.1007/s00394-021-02521-3. Epub 2021 Apr 11. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in adherence to the Mediterranean Diet measured by Mediterranean Diet Adherence Screener (MEDAS) | At baseline, data about adherence to the Mediterranean Diet will be collected by a 14-point Mediterranean Diet Adherence Screener (MEDAS). 4 weeks post-baseline and 6 months post-baseline data from this questionnaire will be also collected. The MEDAS score can range from 0 to 14 and higher scores mean better outcome.
- Unabbreviated scale title: Mediterranean Diet Adherence Screener |
At baseline, after 4 weeks the beginning of intervention and after 6 months the beginning of intervention | |
Primary | Change in the Frequency of Cooking Habits Questionnaire | At baseline, data about the Frequency of Cooking Habits will be collected by a 24-point questionnaire. 4 weeks post-baseline and 6 months post-baseline, data from this questionnaire will be also collected. | At baseline, after 4 weeks the beginning of intervention and after 6 months the beginning of intervention | |
Primary | Change in the Confidence towards cooking Questionnaire | At baseline, data about the Confidence towards cooking will be collected by a 18-point questionnaire. 4 weeks post-baseline and 6 months post-baseline data from this questionnaire will be also collected. The Confidence towards cooking questionnaire can range from 18 to 90 and higher scores mean better confidence. | At baseline, after 4 weeks the beginning of intervention and after 6 months the beginning of intervention | |
Primary | Change in the Attitude towards cooking Questionnaire | At baseline, data about the attitute towards cooking will be collected by a 18-point questionnaire. 4 weeks post-baseline and 6 months post-baseline data from this questionnaire will be also collected. The Attitude towards cooking questionnaire can range from 18 to 90 and higher scores mean better confidence | At baseline, after 4 weeks the beginning of intervention and after 6 months the beginning of intervention | |
Secondary | Change in biochemical parameters (Fasting glucose) | At baseline blood samples will be collected to measure fasting glucose levels. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in biochemical parameters (Fasting insulin) | At baseline blood samples will be collected to measure fasting insulin level. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in biochemical parameters (Fasting total cholesterol) | At baseline blood samples will be collected to measure fasting total cholesterol levels. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in biochemical parameters (Fasting HDL cholesterol) | At baseline blood samples will be collected to measure fasting HDL cholesterol levels. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in biochemical parameters (Fasting LDL cholesterol) | At baseline blood samples will be collected to measure fasting LDL cholesterol levels. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in biochemical parameters (C reactive protein levels) | At baseline blood samples will be collected to measure fasting C reactive protein levels. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in biochemical parameters (TNFalpha) | At baseline blood samples will be collected to measure TNFalpha levels. The second measurement of this parameter will be conducted 4 weeks post-baseline. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in advanced glycation end products (AGEs) level | At baseline blood samples will be collected for determination of advanced glycation end products levels. 4 weeks post-baseline this determination will be repeated. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Changes in body mass index (BMI) | BMI will be calculated as body weight (kg) divided by height (m) squared at baseline and 4 weeks post-baseline | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in fat mass | At baseline and 4 weeks post-baseline, fat mass will be analyzed by bioimpedance. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in fat free mass | At baseline and 4 weeks post-baseline, fat free mass will be analyzed by bioimpedance. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Changes in hip circumference | At baseline, hip circumference will be measured with a measuring. 4 weeks post-baseline, the determination of this measurement will be repeated | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Changes in waist circumference | At baseline, waist circumference will be measured with a measuring. 4 weeks post-baseline, the determination of this measurement will be repeated | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in blood pressure | At baseline, blood pressure will be measured with a measuring. 4 weeks post-baseline, the determination of this measurement will be repeated | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in advanced glycation end products (AGEs) in tissue | At baseline, blood pressure will be measured with a measuring. 4 weeks post-baseline, the determination of this measurement will be repeated. | At baseline and after 4 weeks the beginning of intervention | |
Secondary | Change in dietary intake measured by validated Food Frequency Questionnaire (FFQ) | At baseline data about dietary intake will be collected by using a Food Frequency Questionnaire (FFQ) and 4 weeks post-baseline, these data will be collected again. 6 months post-baseline, these data will be also collected. The FFQ is a 136-item questionnaire | At baseline, after 4 weeks the beginning of intervention and after 6 months the beginning of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |